A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

Name: A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD
License: Public Domain

Liquidia Technologies, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

pulmonary arterial hypertension, pulmonary hypertension due to lung diseases

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 390981
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.